Volume 3, Issue 1 And 2 (1-2015)                   JoMMID 2015, 3(1 And 2): 35-37 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nemati A H, Solgi H, Vaziri F, Shahcheraghi F. Antimicrobial Susceptibility of Stenotrophomonas maltophilia Clinical Isolates from Blood Samples in Iran. JoMMID. 2015; 3 (1 and 2) :35-37
URL: http://jommid.pasteur.ac.ir/article-1-102-en.html
Bacteriology department, pasteur Institute of Iran, Tehran, Iran
Abstract:   (4555 Views)

Introduction: Stenotrophomonas maltophilia is a nosocomial multi drug resistant opportunistic pathogen which causes infections in vulnerable patients with cancer, cystic fibrosis and indwelling catheters. Methods: 45 clinical S. maltophilia isolates were collected from blood samples and identified by biochemical tests. Susceptibility to different antibiotics including co-trimoxazole, levofloxacin, minocycline, ticarcillin/clavulanic acid, chloramphenicol and ceftazidime were determined by disk diffusion and E-test methods. Results: All isolates were resistant to ceftazidime and susceptible to co-trimoxazole and  11.1% were resistant to ticarcillin/clavulanic acid. Conclusion: Ceftazidime as one of the extended spectrum β-lactams was the least effective antibiotic. Ticarcillin/clavulanic acid is one of the choosen antibiotics for S. maltophilia infections treatment. Here, we report tcarcillin/clavulanic acid resistance in S. maltophilia isolates for the first time in Iran.

Full-Text [PDF 252 kb]   (1832 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2016/09/5 | Accepted: 2016/10/4 | Published: 2016/12/10

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.